Extracorporeal Shockwave Therapy for Peyronie's Disease: Who Benefits?
Authors:
- 1 February 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Endourology
- Vol. 20 (2) , 135-138
Abstract
Background and Purpose: Extracorporeal shockwave therapy (ESWT) has been reported to improve the symptoms of Peyronie's disease. However, the response rates to this treatment appear to be variable. This study aimed to determine whether any patient or plaque characteristics are associated with a better outcome. Patients and Methods: A series of 36 patients with Peyronie's disease received ESWT as a primary treatment. Subjective response rates were compared on the basis of patient age, degree of pretreatment penile curvature, predisposing medical factors, duration of disease, and extent of plaque calcification. Results: Ten men (27.8%) reported subjective improvements in curvature after ESWT. Of the factors considered, only age and pretreatment curvature influenced outcomes: 50% of the men below the mean age reported improvement compared with 5.6% of older men and 62.5% of men with mild curvature reported improvement compared with 8.3% of those with severe curvature. Conclusion: The response to EWST is not the same for all men with Peyronie's disease. Younger men and those with milder curvature have the best outcomes.Keywords
This publication has 25 references indexed in Scilit:
- Potassium Paraaminobenzoate (POTABA™) in the Treatment of Peyronie's Disease: A Prospective, Placebo-Controlled, Randomized StudyEuropean Urology, 2005
- Surgical alternatives for treating Peyronie's diseaseBJU International, 2004
- SUBJECTIVE AND OBJECTIVE ANALYSIS OF THE PREVALENCE OF PEYRONIE’S DISEASE IN A POPULATION OF MEN PRESENTING FOR PROSTATE CANCER SCREENINGJournal of Urology, 2004
- A Retrospective Review of 307 Men With Peyronie’s DiseaseJournal of Urology, 2002
- Experience With Intraplaque Injection of Verapamil for Peyronie’s DiseaseJournal of Urology, 2002
- Treatment of Peyronie's disease with local interferon‐α 2bBJU International, 2001
- Corporal plication for penile curvature caused by Peyronie's disease: the patients' perspectiveBJU International, 2001
- Low-dose radiotherapy in 179 patients with Peyronie’s disease: Treatment outcome and current sexual functioningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Treatment of Peyronie's disease with oral colchicine: long‐term results and predictive parameters of successful outcomeInternational Journal Of Impotence Research, 2000
- TAMOXIFEN VERSUS PLACEBO IN THE TREATMENT OF PEYRONIE’S DISEASEJournal of Urology, 1999